About the project

TREGeneration is a research project funded by the European Union's Horizon 2020 Framework Programme for Research and Innovation. Its full title is "Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes".

 

TREGeneration, the official acronym, blends the two terms Treg and regeneration: Treg as an abbreviation of the donor regulatory T cells infused, and regeneration as an allusion to the improvement of tissue damage caused by graft versus host disease (GVHD) after hematopoietic stem cell transplantation (HSCT).

 

The consortium comprises 8 partners from 5 different European countries and a third party in the USA.

 

On the following pages, you find detailed information about the work that is done in the project, the people and institutions that are involved, and Graft versus host disease, the illness for which the project is trying to help find a cure.

The TREGeneration partners

TREGeneration Work Packages

Search
Home
Menu
Top

Newsletter Subscription

Please fill in the information of your subscription.

 

You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

News Section

Paul Ehrlich Institute approves cGVHD Trial Read more

Social Media

LinkedIn TREGeneration